Melanotan 2
US$ 29.53
melanotic sarcoma of heart Metastatic Tumors When the Primary Malignancy Is
Description
View in: Pubmed Clinical activity of pertuzumab (rhuMab 2C4) in advanced, refractory or recurrent ovarian cancer (OC), and the role of HER2 activation status
(PubMed) Diez-Ricote L, San-Cristobal R, Concejo MJ, et al
doi: 10.2334/josnusd.19-0141, 86 TanakaS.SekiS.OnoY.EnomotoA.KogoM
Play your audio in advance Listen to your audio before uploading to make sure it's clean and well-paced
Our team looks at the full picture and stays with you through every stage
Informed consent was obtained from all individual participants included in the study
